Dow Up 0.11% Nasdaq Up 0.50%

Xencor, Inc. (XNCR)

-NasdaqGM
10.69 Up 0.40(3.89%) Aug 29, 4:00PM EDT
Prev Close:10.29
Open:10.27
Bid:10.67 x 1000
Ask:10.74 x 1600
1y Target Est:17.75
Beta:N/A
Next Earnings Date:N/A
Day's Range:10.06 - 10.90
52wk Range:5.75 - 14.41
Volume:29,727
Avg Vol (3m):61,375
Market Cap:335.61M
P/E (ttm):N/A
EPS (ttm):-2.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for XNCR

Comparison

Symbol% ChgMkt Cap
XNCRUp 3.89%335.61M
ABBVDown 0.58%87.99B
GSKUp 0.47%117.94B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.67
Quarterly EPS Est (Sep-14) :-0.19
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback